Recessions are usually called after they’ve already started. That’s why by the time official confirmation comes, markets may ...

Here are the latest stock rating downgrades by Seeking Alpha analysts: Nvidia (NASDAQ:NVDA). Buy to hold by Oakoff ...

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...

Stay on our website for longer than five minutes and you’re bound to find references to Schaeffer’s Volatility Scorecard (SVS ...

Thermo Fisher has unleashed its next-generation TruNarc Delta and Tau Handheld Narcotics Analyzers to help law enforcement ...

By Lauren Ward for Hims May is National Burger Month and Hims is helping you celebrate with a roundup of the healthiest fast ...

If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi ...

Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s expectations, but shares fell hard in after-hours trading ...

Hims & Hers Health, Inc (NYSE:HIMS) is facing heavy selling pressure Thursday morning as the U.S. Food and Drug Administration's (FDA) ban of compounded drugs with semaglutide takes effect.

Hims & Hers (NYSE: HIMS) has put investors on a roller coaster ride in 2025. *Stock prices used were the afternoon prices of ...

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.